COVID Testing Kit Market To Be Motivated By A CAGR Of 6.58% By 2027

Posted by Apeksha on July 24th, 2021

Global COVID Testing Kit Market: Information by Type (Rapid Test Kit, RT-PCR and others), Application (Hospitals, Clinics and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027

COVID Testing Kit Market-Overview

The shortage of testing kits initially has now contributed to several companies contributing to the production of kits to meet the demand, thus boosting the COVID testing kit market share. The development of the production potential in other ancillary sectors is estimated to bolster the COVID testing kit market in the forthcoming period.

Detailed Regional Analysis 

The regional overview of the COVID testing kit market consists of Europe, Asia Pacific, North America and other chief regional markets. The European COVID testing kit market reported for the prime market share in the global market. The elevated COVID-19 illness and mortality detected among inhabitants in long-term care facilities (LTCF) in E.U. nations pose the main challenge for disease prevention and control in such surroundings.

Competitive Analysis

The vital contenders in the COVID testing kit market are Bio-Rad Laboratories, Inc. (U.S.), Qiagen (Germany), GenMark (U.S.), Mayo Clinic Laboratories (U.S.), Chembio Diagnostic Systems, Inc. (U.S.), Dynamiker Biotechnology (Tianjin) Co., Ltd (China), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Henry Schein, Inc. (U.S.), Zhejiang Orient Gene Biotech Co., Ltd. (China), Thermo Fisher Scientific Inc. (U.S.), Siemens AG (Germany), BioMérieux SA (France), Guangzhou Wondfo Biotech (China), Abbott (U.S.), Robert Bosch GmbH (Germany), Cellex (U.S.), Mount Sinai Laboratory (U.S.), and Biomedomics Inc. (U.S.),

Browse Detailed TOC with COVID-19 Impact Analysis at:


Akash Anand

Market Research Future

+1 646 845 9312


Like it? Share it!


About the Author

Joined: April 9th, 2018
Articles Posted: 489

More by this author